Precigen has won approval in the US for a first-in-class immunotherapy for recurrent respiratory papillomatosis (RRP), a rare ...

In another sign of increased regulatory scrutiny of vaccines in the US, Health and Human Services (HHS) Secretary Robert F ...

The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

Regulatory agencies are offering more flexibility when it comes to viral clearance strategies, but this must be aligned with ...

Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...

Confirmation of that has come in the form of an update (PDF) from the New Jersey Department of Labour and Workforce ...

The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...

Eli Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro for people who buy the drug ...

Yantai-based RemeGen said it will now move ahead with filing telitacicept with China's National Medical Products ...

“Sexuality and intimacy are important aspects of quality of life and may also reduce some of the psychosocial distress ...

AstraZeneca's Fasenra has been cleared for use by the NHS in England as an add-on treatment for the rare autoimmune disease ...

The deal – which has a total value of up to $1.3 billion including an unspecified upfront payment – gives Bayer exclusive ...